Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Adagio Medical | ADGM | 5. nov 2024 | 2.92 | +7.75 |
Adams Diversified Equity Fund | ADX | 5. nov 2024 | 21.79 | +0.74 |
Adams Natural Resources Fund | PEO | 5. nov 2024 | 23.66 | -0.21 |
Adams Resources & Energy | AE | 5. nov 2024 | 27.50 | 0.00 |
AdaptHealth | AHCO | 5. nov 2024 | 9.18 | -9.56 |
Adaptimmune Therapeutics ADR | ADAP | 5. nov 2024 | 0.83 | +0.30 |
Adaptive Biotechnologies | ADPT | 5. nov 2024 | 5.58 | +6.08 |
ADC Therapeutics SA | ADCT | 5. nov 2024 | 3.05 | +0.99 |
Addentax Group | ATXG | 5. nov 2024 | 0.62 | +1.46 |
Addex Therapeutics ADR | ADXN | 5. nov 2024 | 11.08 | +1.09 |
Addus HomeCare | ADUS | 5. nov 2024 | 124.17 | -3.71 |
Adecoagro | AGRO | 5. nov 2024 | 11.36 | -0.87 |
Adeia | ADEA | 5. nov 2024 | 12.79 | +1.99 |
Adial Pharmaceuticals | ADIL | 5. nov 2024 | 1.01 | +0.50 |
Adicet Bio | ACET | 5. nov 2024 | 1.31 | +3.97 |
Adient | ADNT | 5. nov 2024 | 19.72 | -0.10 |
Aditxt | ADTX | 5. nov 2024 | 0.47 | -3.35 |
Adlai Nortye | ANL | 5. nov 2024 | 2.27 | +11.82 |
ADMA Biologics | ADMA | 5. nov 2024 | 18.83 | -1.47 |
Adobe | ADBE | 5. nov 2024 | 486.42 | +1.05 |
ADS-TEC | ADSE | 5. nov 2024 | 14.11 | +1.58 |
ADT | ADT | 5. nov 2024 | 7.36 | +0.55 |
Adtalem Global Education | ATGE | 5. nov 2024 | 81.28 | +0.86 |
ADTRAN | ADTN | 5. nov 2024 | 6.19 | -0.16 |
Advance Auto Parts | AAP | 5. nov 2024 | 38.16 | +1.90 |
Advanced Drainage Systems | WMS | 5. nov 2024 | 155.25 | +2.01 |
Advanced Energy Industries | AEIS | 5. nov 2024 | 111.39 | +1.20 |
Advanced Flower Capital | AFCG | 5. nov 2024 | 9.85 | +1.44 |
Advanced Micro Devices | AMD | 5. nov 2024 | 141.66 | +0.68 |
AdvanSix | ASIX | 5. nov 2024 | 29.64 | -0.50 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.